Skip to main content
CriticalFDAfda-F-2436-2014SALMONELLA CONTAMINATION

Green Vibrance, 240 Vegicaps/bottle Product Code: GVC

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
5,355
Recall Date
July 25, 2014
Issuing Agency
Hazard
Salmonella Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2436-2014.

A raw material used in the manufacture of the dietary supplements was found to contain Salmonella bacteria.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2436-2014.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Vibrant Health or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2436-2014.

Vibrant Health

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Vibrant Health Recall FAQ

Vibrant Health is the subject of a food safety report: Green Vibrance, 240 Vegicaps/bottle Product Code: GVC. The notice was published on July 25, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 5,355 units are potentially affected.